Search

Displaying results 8111 - 8120 of 9314 in total
  1. Drug

    AZD-3043

    go.drugbank.com/drugs/DB12576
    Investigational

    AZD3043 has been used in trials studying the treatment and basic science of Safety, Sedation, Tolerability, and Pharmacokinetics.

  2. Drug

    JNJ-41443532

    go.drugbank.com/drugs/DB12632
    Investigational

    JNJ-41443532 has been used in trials studying the basic science and treatment of Diabetes Mellitus, Type 2.

  3. Drug

    Samalizumab

    go.drugbank.com/drugs/DB12636
    Investigational

    Samalizumab has been used in trials studying the treatment of Multiple Myeloma and B-cell Chronic Lymphocytic Leukemia.

  4. Drug

    Nelivaptan

    go.drugbank.com/drugs/DB12643
    Investigational

    Nelivaptan has been used in trials studying the treatment of Anxiety Disorders, Depressive Disorder, and Major Depressive Disorder.

  5. Drug

    GS-9256

    go.drugbank.com/drugs/DB12876
    Investigational

    GS-9256 has been used in trials studying the treatment of HCV Infection and Chronic Hepatitis C Infection.

  6. Drug

    Carbendazim

    go.drugbank.com/drugs/DB13009
    Investigational

    Carbendazim has been used in trials studying the treatment of Lymphoma and Unspecified Adult Solid Tumor, Protocol Specific.

  7. Drug

    Odalasvir

    go.drugbank.com/drugs/DB13041
    Investigational

    Odalasvir has been used in trials studying the treatment of Hepatitis C, Chronic and Chronic Hepatitis C Infection.

  8. Drug

    Topramezone

    go.drugbank.com/drugs/DB14826
    Experimental

    Topramezone is under investigation in clinical trial NCT00559520 (The Role of Preoperative Oral Immunonutrition in Major Vascular Surgery).

  9. Drug

    ZK-93423

    go.drugbank.com/drugs/DB17063
    Experimental

    ZK-93423 is a beta-carboline with muscle relaxant activity with agonistic properties at the benzodiazepine receptor.[A253172]

  10. Drug

    QL1706

    go.drugbank.com/drugs/DB17562
    Investigational

    QL1706 is an investigational bifunctional antibody that combines the activity of both PD-1 and CTLA-4 antibodies.